TPCW
BIIB icon

TD Private Client Wealth’s Biogen BIIB Stock Holding History

TD Private Client Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$350K Buy
1,909
+1,452
+318% +$268K 0.01% 546
2025
Q4 		$80.4K Buy
457
+43
+10% +$7.03K ﹤0.01% 799
2025
Q3 		$58K Buy
414
+76
+22% +$10.3K ﹤0.01% 832
2025
Q2 		$42.4K Buy
338
+326
+2,717% +$40.6K ﹤0.01% 872
2025
Q1 		$1.64K Sell
12
-40
-77% -$5.72K ﹤0.01% 1218
2024
Q4 		$7.95K Sell
52
-333
-86% -$56.2K ﹤0.01% 1068
2024
Q3 		$74.6K Buy
385
+77
+25% +$16.1K ﹤0.01% 765
2024
Q2 		$71.4K Sell
308
-28
-8% -$6.08K ﹤0.01% 740
2024
Q1 		$72.5K Sell
336
-2,797
-89% -$655K ﹤0.01% 749
2023
Q4 		$811K Sell
3,133
-294
-9% -$72.2K 0.03% 362
2023
Q3 		$881K Sell
3,427
-961
-22% -$257K 0.04% 329
2023
Q2 		$1.25M Sell
4,388
-289
-6% -$86K 0.05% 297
2023
Q1 		$1.3M Sell
4,677
-210
-4% -$58.1K 0.06% 284
2022
Q4 		$1.35M Sell
4,887
-818
-14% -$231K 0.06% 271
2022
Q3 		$1.52M Sell
5,705
-47
-0.8% -$9.98K 0.08% 240
2022
Q2 		$1.17M Buy
5,752
+724
+14% +$148K 0.06% 290
2022
Q1 		$1.06M Buy
5,028
+4,773
+1,872% +$1.04M 0.05% 328
2021
Q4 		$61.2K Sell
255
-63
-20% -$16.2K ﹤0.01% 715
2021
Q3 		$90K Sell
318
-24
-7% -$7.87K ﹤0.01% 643
2021
Q2 		$118K Buy
342
+24
+8% +$7.27K 0.01% 595
2021
Q1 		$89K Buy
318
+28
+10% +$7.55K ﹤0.01% 617
2020
Q4 		$71K Sell
290
-113
-28% -$29.2K ﹤0.01% 606
2020
Q3 		$114K Sell
403
-287
-42% -$80K 0.01% 516
2020
Q2 		$185K Sell
690
-131
-16% -$39.4K 0.01% 460
2020
Q1 		$260K Sell
821
-1,999
-71% -$607K 0.02% 391
2019
Q4 		$837K Buy
+2,820
New +$782K 0.05% 285

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TD Private Client Wealth's BIIB Position: Q1 2026 in Review

TD Private Client Wealth increased its Biogen (BIIB) stake by 318% in Q1 2026, buying an estimated $268K and bringing the position to 1,909 shares worth $350K. The position accounts for 0.01% of the portfolio, ranked #546.

TD Private Client Wealth first reported a position in BIIB in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.52M in Q3 2022. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • TD Private Client Wealth held 1,909 shares of Biogen worth $350K as of Q1 2026.
  • TD Private Client Wealth bought 1,452 Biogen shares in Q1 2026, an estimated $268K.
  • Biogen made up 0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #546 holding.
  • TD Private Client Wealth first reported a position in Biogen in Q4 2019 and has held it in 26 quarters since.
  • TD Private Client Wealth's Biogen position peaked at $1.52M in Q3 2022.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.